Inflammatix grabs $102m Series D
Inflammatix, a molecular diagnostics company, has secured $102 million in Series D financing.
Inflammatix, a molecular diagnostics company, has secured $102 million in Series D financing.
Copyright PEI Media
Not for publication, email or dissemination